MTOR and cancer: In this research work, the underlying mechanism is not investigated, but it could be speculated that the dysregulation of Wnt and PI3K/AKT/mTOR signaling pathways, caused by an altered methylation status in a variety of genes, was described to be associated with resistance to standard treatments in many types of cancer (106).